Modulation by oestrogen and progestins/antiprogestins of alpha interferon receptor expression in human breast cancer cells
- 1 January 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 143-146
- https://doi.org/10.1016/0277-5379(91)90473-q
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditionsBritish Journal of Cancer, 1990
- Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotypeBritish Journal of Cancer, 1989
- Interferon receptorsIn Vitro Cellular & Developmental Biology, 1988
- Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitises them to the anti-proliferative effects of tamoxifenBritish Journal of Cancer, 1987
- Recombinant interferon in advanced breast cancerBritish Journal of Cancer, 1984
- Recombinant Leukocyte A Interferon in Advanced Breast CancerAnnals of Internal Medicine, 1983
- Administration of fibroblast interferon to patients with advanced breast cancer: Possible effects on skin metastasis and on hormone receptorsEuropean Journal of Cancer and Clinical Oncology, 1982
- Effects of HuIFN-α2 and HuIFN-α (Namalwa) on Breast Cancer Cells Grown in Culture and as Xenografts in the Nude MouseJournal of Interferon Research, 1982
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978